Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Tracking the healing of chronic venous leg ulcers with a special foam dressing

Official title: A Prospective, Open, Multi-Center, Interventional, Non-Comparative Clinical Investigation to Follow the Progress of Exuding Venous Leg Ulcers Using a Non-Bordered Foam Dressing

Run by Molnlycke Health Care AB · NCT05608317 · Data updated 2026-11-12

This study is testing a special foam dressing to see if it helps people with chronic venous leg ulcers heal better over six weeks.

More Venous Leg Ulcer trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorMolnlycke Health Care AB
Industry-sponsored
Locations3 sites (San Francisco, California and 2 other locations)
StatusRecruiting
StartedNovember 8, 2022
Main results expectedJuly 30, 2024
Study endsNovember 30, 2024
Registry record updatedMay 6, 2024
Trial IDNCT05608317 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with chronic, exuding venous leg ulcers that meet specific size and exudate criteria.

Probably not a fit

Patients with infected ulcers or known allergies to the dressing materials may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical investigation aims to monitor the healing process of chronic venous leg ulcers (VLUs) using a non-bordered foam dressing over a period of up to six weeks. Participants will wear the dressing, which will be changed weekly, while their wound progress is assessed through objective measurements and subjective evaluations of pain, comfort, and quality of life. The study will involve multiple visits to the investigation site to ensure thorough monitoring and safety assessments. A total of 20 participants will be recruited across six centers in the US and Canada.

Why it matters

Potential benefit: If successful, this study could improve healing outcomes for patients with chronic venous leg ulcers.

How similar studies have gone: While similar approaches have been explored, this specific investigation focuses on a novel dressing type for chronic venous leg ulcers.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Signed consent to participate (including consent for digital imaging)
* Adult aged ≥18 years
* Diagnosed with a chronic, exuding VLU
* Exudate amount moderate to large
* Wound size from 3 cm2 to 30 cm2, as determined by the clinician
* ABPI (within 3 months) \> 0.7. If ABPI \> 1.4, then big toe pressure \> 60 mmHg is required or an alternative measurement verifying normal distal arterial flow
* Willing to be compliant with compression therapy

Exclusion Criteria:

* Infected ulcer according to the judgment of the investigator defined as any wound condition requiring the prescription or continuation of systemic antibiotic therapy at enrollment
* Circumferential wound
* Known allergy/hypersensitivity to the materials of the dressing
* Use of wound fillers

Where it's running

  • University of Miami
    Miami, Florida, United States
    Recruiting
  • Serena Group Research Institute
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Center for Clinical Trials, Inc.
    San Francisco, California, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Tracking the healing of chronic wounds with a special dressing

    This study is testing a special dressing called Mepilex Up to see if it helps people with chronic wounds, like venous leg ulcers and diabetic foot ulcers, heal better over six weeks.

    Recruiting at 4 sites Molnlycke Health Care AB · Castro Valley, California and 3 other locations · NCT05588583

  • Tissue Repair Gel for treating Venous Leg Ulcers

    This study is testing a new gel to see if it helps people with stubborn leg ulcers heal better when used with standard treatment compared to standard treatment alone.

    Recruiting at 24 sites Phase 3 TR Therapeutics · Tucson, Arizona and 32 other locations · NCT06707090

  • 4-aminopyridine for faster skin wound healing

    This trial will see if 4-aminopyridine helps small skin wounds heal faster in healthy adults aged 18–70.

    Recruiting Phase 2 University of Arizona · Tucson, Arizona · NCT06333171

  • PAW-hydrogel to help chronic wounds like diabetic foot and leg ulcers heal faster

    This trial will test whether a plasma-activated water–infused Carbopol® 940 hydrogel helps adults with long-standing wounds (diabetic foot, pressure, venous, arterial, or dehiscent ulcers) heal faster and have less bacteria compared with standard advanced wound care.

    Recruiting National Institute of Nuclear Research - Mexico · Ocoyoacac, State of Mexico · NCT07541196

  • GORE VIABAHN FORTEGRA Venous Stent Post-Approval Study

    This study tests the GORE VIABAHN FORTEGRA Venous Stent in real-world patients with venous diseases to see how it performs after it is approved.

    Recruiting at 4 sites W.L.Gore & Associates · Darien, Connecticut and 3 other locations · NCT07538609

  • Human placental membrane products plus standard care for nonhealing diabetic foot and venous leg ulcers

    This trial will try human placental membrane products together with standard wound care to help adults whose diabetic foot ulcers or venous leg ulcers have not healed.

    Recruiting BioLab Holdings · Philidelphia, Pennsylvania · NCT07364630

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.